Krastm6Bbd
Targeted Allele Detail
|
|
| Symbol: |
Krastm6Bbd |
| Name: |
Kras proto-oncogene, GTPase; targeted mutation 6, Mariano Barbacid |
| MGI ID: |
MGI:7526733 |
| Synonyms: |
KrasFSFG12Vlox |
| Gene: |
Kras Location: Chr6:145162425-145195965 bp, - strand Genetic Position: Chr6, 77.37 cM, cytoband G2
|
| Alliance: |
Krastm6Bbd page
|
|
|
|
| Allele Type: |
|
Targeted (Conditional ready, Humanized sequence, Null/knockout) |
| Mutations: |
|
Insertion, Nucleotide substitutions
|
| |
|
Mutation details: An FRT site flanked hygromycin resistance gene and STOP cassette and a loxP site were inserted into intron 1 and a second loxP site into intron 2. Exon 2, the first coding exon, was modified by changing glycine codon 12 (GGT) to valine (GTA) (p.G12V). The allele will only be expressed after Flp-mediated removal of the hygro-STOP cassette. The mutation is the equivalent of the same human mutation found in lung adenocarcinoma.
(J:334559)
|
|
|
| Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
| Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
| Carrying any Kras Mutation: |
69 strains or lines available
|
|
| Original: |
J:334559 Salmon M, et al., Kras oncogene ablation prevents resistance in advanced lung adenocarcinomas. J Clin Invest. 2023 Apr 3;133(7) |
| All: |
1 reference(s) |
|